Human umbilical cord matrix-derived stem cells exert trophic effects on β-cell survival in diabetic rats and isolated islets

Human umbilical cord matrix-derived stem cells (uMSCs), owing to their cellular and procurement advantages compared with mesenchymal stem cells derived from other tissue sources, are in clinical trials to treat type 1 (T1D) and type 2 diabetes (T2D). However, the therapeutic basis remains to be full...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yunting, Hu, Qi, Chen, Fuyi, Zhang, Juan, Guo, Jincheng, Wang, Hongwu, Gu, Jiang, Ma, Lian, Ho, Guyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728317/
https://www.ncbi.nlm.nih.gov/pubmed/26398949
http://dx.doi.org/10.1242/dmm.021857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728317/
https://www.ncbi.nlm.nih.gov/pubmed/26398949
http://dx.doi.org/10.1242/dmm.021857

Ejemplares similares